Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Haibo Biotechnology is a Chinese life sciences company specializing in the field of microbiology and clinical diagnostics. Based in Hangzhou, the company focuses on the research, development, and production of high-quality microbial culture media, automated laboratory equipment, and in vitro diagnostic (IVD) reagents. Its product portfolio serves a variety of sectors, including clinical medicine, food safety, environmental monitoring, and pharmaceutical quality control. Zhejiang Haibo is particularly recognized for its automated systems for sample pretreatment and microbial identification, which aim to improve laboratory efficiency and accuracy. The company operates as a significant provider of laboratory consumables and diagnostic solutions within the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Haibo Biotechnology.